Which Patients Report That Their Urologists Advised Them to Forgo Initial Treatment for Prostate Cancer?

Urology
Archana RadhakrishnanCraig Evan Pollack

Abstract

To examine how frequently patients report that their urologist recommended forgoing definitive treatment and assess the impact of these recommendations on treatment choice and perceived quality of cancer care. We mailed surveys to men newly diagnosed with localized prostate cancer between 2014 and 2015 (adjusted response rate of 51.3%). Men reported whether their urologist recommended forgoing definitive treatment. Using logistic regression models, we assessed patient-level predictors of receiving a recommendation to forgo definitive treatment and estimated associations of receiving this recommendation with receipt of definitive treatment and perceived quality of cancer care among men with low-risk tumors and limited life expectancies. Nearly two-thirds (62.2%) of men with low-risk tumors and 46.4% with limited life expectancies received recommendations from their urologists to forgo definitive treatment. Among men with limited life expectancies, those with low-risk tumors were more likely to receive this recommendation compared with men with high-risk tumors (odds ratio [OR] 3.41; 95% confidence interval [CI] 2.17-5.37). Men with low-risk tumors who were recommended to forgo definitive treatment were less likely to receive def...Continue Reading

References

May 5, 2005·JAMA : the Journal of the American Medical Association·Peter C AlbertsenJudith Fine
Jun 9, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R G HagertyM H N Tattersall
Aug 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John Z AyanianDavid P Harrington
Apr 22, 2011·BJU International·B Joyce Davison, S Larry Goldenberg
Apr 27, 2011·The Prostate·Abhinav SidanaJonathan I Epstein
Jul 4, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer W Mack, Thomas J Smith
Nov 9, 2012·Journal of the American Board of Family Medicine : JABFM·Jinping XuKendra L Schwartz
Jan 17, 2013·Journal of the American Geriatrics Society·Julie N ThaiAlexander K Smith
Mar 7, 2013·JAMA : the Journal of the American Medical Association·Marisa CruzSei J Lee
Mar 31, 2015·European Urology·Jesse D SammonQuoc-Dien Trinh
Jul 8, 2015·JAMA : the Journal of the American Medical Association·Matthew R Cooperberg, Peter R Carroll
Jul 15, 2015·Patient Preference and Adherence·Timothy N ShowalterJohn Fp Bridges
Jan 7, 2016·Journal of the National Comprehensive Cancer Network : JNCCN·James L MohlerDeborah A Freedman-Cass
Feb 18, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald C ChenSuneil Jain
Mar 10, 2016·Nature Reviews. Urology·Jeffrey J TosoianStacy Loeb
Apr 12, 2016·JAMA Internal Medicine·Nancy L SchoenbornCynthia Boyd
Oct 22, 2016·JAMA Oncology·Stacy LoebPär Stattin
Jun 13, 2017·JAMA Internal Medicine·Nancy L SchoenbornCynthia Boyd

❮ Previous
Next ❯

Citations

Jan 25, 2020·Journal of Endourology·Ryan W DobbsDavid I Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved